# # # BPC-157 went into human trials in Europe years ago under a code name, PL 14736, run by the Croatian drug maker Pliva
The sooner treatment begins, the better the outcome
Combining Multiple Copper Peptides In some cases, using multiple copper peptide types provides benefits that single-peptide protocols cannot achieve
The options may be chosen on the product page What is AOD-9604
If you are looking for relief from an orthopedic condition, see one of our board-certified physicians who specialize in Interventional Regenerative Orthopedics
One should not use AOD-9604 if they: Are pregnant or breastfeeding Are a minor Have a current or recent history of cancer (particularly hormone-sensitive cancers) Have uncontrolled diabetes or significant insulin resistance Have active thyroid disease that is not well-managed Are taking medications that may interact with peptide therapy (discuss with your provider) Have a known hypersensitivity to peptide compounds Comprehensive labs including metabolic panel, fasting glucose, HbA1c, thyroid panel, lipid panel, and hormone levels should be run before starting any peptide therapy and monitored regularly throughout
